Michael F Parry, MD in Stamford, CT - Medicare Infectious Disease

Michael F Parry, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Stamford, Connecticut. He went to University Of Missouri, Columbia School Of Medicine and graduated in 1970 and has 54 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Stamford Health Medical Group Inc and his current practice location is 29 Hospital Plaza, Suite 605, Stamford, Connecticut. You can reach out to his office (for appointments etc.) via phone at (203) 353-1427.

Michael F Parry is licensed to practice in Connecticut (license number 018007) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1578535431.

Contact Information

	Michael F Parry, MD
	29 Hospital Plaza, Suite 605, Stamford, CT 06902-3602
	(203) 353-1427
	(203) 276-7775

Physician's Profile

Full Name	Michael F Parry
Gender	Male
Speciality	Infectious Disease
Experience	54 Years
Location	29 Hospital Plaza, Stamford, Connecticut
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Michael F Parry attended and graduated from University Of Missouri, Columbia School Of Medicine in 1970

NPI Data:

NPI Number: 1578535431
Provider Enumeration Date: 02/06/2006
Last Update Date: 01/13/2017

Medicare PECOS Information:

PECOS PAC ID: 3072608710
Enrollment ID: I20101029000244

Medical Identifiers

Medical identifiers for Michael F Parry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1578535431	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RI0200X	Internal Medicine - Infectious Disease	018007 (Connecticut)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Stamford Hospital	Stamford, CT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Stamford Health Medical Group Inc	6901099746	355

News Archive

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease - a necessary step in achieving an optimum treatment.

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and a financial update for the third quarter ended September 30, 2010.

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Emulate, Inc. has formed a collaborative partnership with AstraZeneca's Innovative Medicines and Early Development Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael F Parry allows following entities to bill medicare on his behalf.

Entity Name	Stamford Health Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1154633980 PECOS PAC ID: 6901099746 Enrollment ID: O20101025000743

News Archive

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease - a necessary step in achieving an optimum treatment.

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael F Parry is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Michael F Parry, MD 29 Hospital Plaza, Suite 605, Stamford, CT 06902-3602 Ph: (203) 353-1427	Michael F Parry, MD 29 Hospital Plaza, Suite 605, Stamford, CT 06902-3602 Ph: (203) 353-1427

News Archive

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease - a necessary step in achieving an optimum treatment.

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Internal Medicine Doctors in Stamford, CT

Jeanne M Hosinski, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3 Sweet Briar Rd, Stamford, CT 06905 Phone: 203-968-8101
Dr. Santi J Neuberger, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1290 Summer St, Stamford, CT 06905 Phone: 203-324-9955 Fax: 203-324-0171
Karishma Bellara, PA Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 190 W Broad St, Stamford, CT 06902 Phone: 203-348-2437 Fax: 203-276-7243
Dr. Brian Barry Hennessy, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 90 Morgan St, Ste 202, Stamford, CT 06905 Phone: 203-348-2922 Fax: 203-358-8721
Dr. Andreas Bub, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1 Hospital Plz, Stamford, CT 06902 Phone: 203-276-7147
Katharine Meyers, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 1450 Washington Blvd, Stamford, CT 06902 Phone: 203-327-9321 Fax: 203-967-2140
Dr. Brian Sebastian Wojeck, M.D. M. P.H Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 260 Long Ridge Rd, Stamford, CT 06902 Phone: 203-737-1058

Michael F Parry, MD - Medicare Infectious Disease in Stamford, CT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Medicare Reassignments

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Discovery Labs reports net operating loss of $6.2 million for third quarter 2010

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Internal Medicine Doctors in Stamford, CT